ASPP2κ Is Expressed In Human Colorectal Carcinoma And Promotes Chemotherapy Resistance And Tumorigenesis.

Saved in:
Bibliographic Details
Title: ASPP2κ Is Expressed In Human Colorectal Carcinoma And Promotes Chemotherapy Resistance And Tumorigenesis.
Authors: Rieger I; Department of Oncology, Hematology, Clinical Immunology and Rheumatology, University Hospital Tübingen (UKT), Tübingen, Germany., Tsintari V; Department of Oncology, Hematology, Clinical Immunology and Rheumatology, University Hospital Tübingen (UKT), Tübingen, Germany., Overkamp M; Institute of Pathology at the University Hospital Tübingen, Tübingen, Germany., Fend F; Institute of Pathology at the University Hospital Tübingen, Tübingen, Germany., Lopez CD; Department of Hematology and Medical Oncology, Oregon Health and Science University (OHSU), Portland, OR, United States., Schittenhelm MM; Clinic of Medical Oncology and Hematology, Cantonal Hospital St. Gallen (KSSG), St. Gallen, Switzerland., Kampa-Schittenhelm KM; Department of Oncology, Hematology, Clinical Immunology and Rheumatology, University Hospital Tübingen (UKT), Tübingen, Germany.; Translational Experimental Hematology and Oncology, Medical Research Center and Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Source: Frontiers in molecular biosciences [Front Mol Biosci] 2021 Nov 05; Vol. 8, pp. 727203. Date of Electronic Publication: 2021 Nov 05 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653173 Publication Model: eCollection Cited Medium: Print ISSN: 2296-889X (Print) Linking ISSN: 2296889X NLM ISO Abbreviation: Front Mol Biosci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first